Geko™ KM40C Hydrogel Skin Adhesion Trial (XW-3)

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Leg Ulcer
Interventions
DEVICE

geko™ X-W3

The geko™ X-W3 is a next generation self adhesive medical device incorporating a new formulation skin adhesive. It is about the size of a wrist watch which attaches to the side of the knee and when switched on, gentle painless electrical pulses are produced which contract the calf muscles and increase blood flow to the lower leg. The only difference between the currently used geko™ W3 device and the new geko™ XW-3 device is the adhesive used to attach each device to the skin.

Trial Locations (2)

W10 6DZ

Central London Community Health Care NHS Trust, London

NR2 3TU

Norfolk Community Health and Care NHS Trust, Norwich

All Listed Sponsors
lead

Firstkind Ltd

INDUSTRY

NCT06084546 - Geko™ KM40C Hydrogel Skin Adhesion Trial (XW-3) | Biotech Hunter | Biotech Hunter